IL18 and metabolic dysfunction-associated steatohepatitis: Circulating IL-18 levels correlate with metabolic syndrome (176), but, on the other hand, it has been also demonstrated that IL-18 production negatively regulates NASH progression via modulation of the gut microbiota (177).